For a detailed comparison of how the two medications differ in ways that actually matter, like mechanism of action, dosing protocols , and side effect profiles , see our comprehensive semaglutide vs tirzepatide comparison
For most people, a 5-10% weight loss produces noticeable changes in clothing fit, facial appearance, and physical comfort
[13] In combination with a reduced-calorie diet and increased physical activity, semaglutide (as Wegovy) is indicated to reduce the risk of major adverse cardiovascular events (cardiovascular death, non-fatal myocardial infarction, or non-fatal stroke) in adults with established cardiovascular disease and who are either obese or overweight

For most people, the bigger practical factors are: how quickly weight is coming off whether protein intake is adequate whether resistance training is happening consistently whether strength and body composition are being tracked with more than the scale Who This Matters For This article matters most for: people deciding between semaglutide and tirzepatide people already using one of these drugs and worrying about muscle loss adults over 40 who care about strength, function, and frailty risk readers who want a better body-composition result, not just a lower scale number Key Takeaways both semaglutide and tirzepatide can be associated with some lean-mass loss during weight loss current evidence does not justify a blanket claim that one is always harder on muscle tirzepatide may outperform semaglutide on fat-mass reduction in some comparisons, but its effect on fat-free mass remains uncertain the higher-quality question is not just which drug causes more loss, but how do I protect lean mass while losing fat resistance training, protein, and rate of loss still matter more than medication brand name alone What the Evidence Says The strongest practical conclusion is cautious, not absolute

Human clinical trials show mixed, usually modest effects on body composition